Kristen Kluska
Stock Analyst at Cantor Fitzgerald
Total Price Targets
17
Stocks Covered
12
Sectors
Healthcare, Technology
Most Recent
Mar 13, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Kristen Kluska
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| CAPR | Capricor Therapeutics, Inc. | $62.00 | $31.32 | +98.0% | 1 | Mar 13, 2026 |
| IRON | Disc Medicine, Inc. | $125.00 | $67.31 | +85.7% | 1 | Feb 17, 2026 |
| DBVT | DBV Technologies S.A. | $48.00 | $20.11 | +138.7% | 2 | Dec 17, 2025 |
| FULC | Fulcrum Therapeutics, Inc. | $24.00 | $7.37 | +225.9% | 2 | Dec 8, 2025 |
| TSHA | Taysha Gene Therapies, Inc. | $13.00 | $6.38 | +103.8% | 2 | Nov 14, 2025 |
| ZVRA | Zevra Therapeutics, Inc. | $24.00 | $10.07 | +138.3% | 1 | Nov 6, 2025 |
| ESPR | Esperion Therapeutics, Inc. | $9.00 | $3.12 | +188.5% | 2 | Sep 25, 2025 |
| PTC | PTC Inc. | $120.00 | $136.66 | -12.2% | 1 | Jul 29, 2025 |
| SRPT | Sarepta Therapeutics, Inc. | $20.00 | $21.60 | -7.4% | 2 | Jun 16, 2025 |
| CDXS | Codexis, Inc. | $11.00 | $2.67 | +311.2% | 1 | May 30, 2024 |
| SKYE | Skye Bioscience, Inc. | $21.00 | $0.83 | +2440.5% | 1 | May 23, 2024 |
| PTCT | PTC Therapeutics, Inc. | $63.00 | $65.06 | -3.2% | 1 | Apr 5, 2022 |
Recent Activity
- Mar 13, 2026— Set$62.00price target onCAPR(Capricor Therapeutics, Inc.)
- Feb 17, 2026— Set$125.00price target onIRON(Disc Medicine, Inc.)
- Dec 17, 2025— Set$48.00price target onDBVT(DBV Technologies S.A.)
- Dec 14, 2025— Set$42.00price target onDBVT(DBV Technologies S.A.)
- Dec 8, 2025— Set$24.00price target onFULC(Fulcrum Therapeutics, Inc.)
- Nov 14, 2025— Set$13.00price target onTSHA(Taysha Gene Therapies, Inc.)
- Nov 6, 2025— Set$24.00price target onZVRA(Zevra Therapeutics, Inc.)
- Sep 25, 2025— Set$9.00price target onESPR(Esperion Therapeutics, Inc.)
- Jul 29, 2025— Set$120.00price target onPTC(PTC Inc.)
- Jun 16, 2025— Set$20.00price target onSRPT(Sarepta Therapeutics, Inc.)
- Dec 17, 2024— Set$8.00price target onESPR(Esperion Therapeutics, Inc.)
- Nov 7, 2024— Set$167.00price target onSRPT(Sarepta Therapeutics, Inc.)
- May 30, 2024— Set$11.00price target onCDXS(Codexis, Inc.)
- May 23, 2024— Set$21.00price target onSKYE(Skye Bioscience, Inc.)
- May 20, 2024— Set$23.00price target onFULC(Fulcrum Therapeutics, Inc.)
- Apr 5, 2022— Set$63.00price target onPTCT(PTC Therapeutics, Inc.)
- May 19, 2021— Set$44.00price target onTSHA(Taysha Gene Therapies, Inc.)
Frequently Asked Questions
Who is Kristen Kluska?
Kristen Kluska is a stock analyst at Cantor Fitzgerald covering 12 stocks primarily in Healthcare, Technology. They have issued 17 price targets since May 19, 2021.
What stocks does Kristen Kluska cover?
Kristen Kluska currently covers 12 stocks, including DBVT, FULC, TSHA, ESPR, SRPT.
What is Kristen Kluska's latest price target?
Kristen Kluska's most recent price target was $62.00 on CAPR (Capricor Therapeutics, Inc.), set on Mar 13, 2026.
What is Kristen Kluska's highest price target?
Kristen Kluska's highest issued price target is $167.00 on SRPT, set on Nov 7, 2024.
More Analysts at Cantor Fitzgerald
Coverage based on publicly published price targets. Not investment advice.